Insomnia, health-related quality of life and healthcare resource consumption. A study of managed-care organisation enrollees
- PMID: 10346415
- DOI: 10.2165/00019053-199814060-00004
Insomnia, health-related quality of life and healthcare resource consumption. A study of managed-care organisation enrollees
Abstract
Objective: Insomnia is a prevalent sleep complaint which has been reported to be greatly associated with reduced health-related quality of life (HR-QOL) and increased healthcare resource use. This study documents the prevalence of insomnia, and its impact on patients' HR-QOL and healthcare resource use in managed-care settings in the US.
Design and setting: A multi-site survey of 5 American Medical Group Association (AMGA) clinics was conducted. Each clinic mailed questionnaires to 1100 randomly selected individuals enrolled in its healthcare system and distributed questionnaires to 400 individuals during a clinic visit and prior to seeing a physician. The questionnaire was a form of the Health Status Questionnaire with the well-validated Medical Outcomes Study 36-Item Short Form (SF-36) Health Survey, a 3-question depression screen, a sleep questionnaire, demographic variables, and questions about medical encounters and prescription and over-the-counter (OTC) drug use.
Main outcome measures and results: Approximately one-third of managed-care enrollees in this study reported insomnia with daytime dysfunction. Individuals with insomnia reported lower HR-QOL scores and increased healthcare resource use compared with individuals with no insomnia. After controlling for demographic variable and comorbid conditions, the negative association of insomnia remained significant on all HR-QOL scores, emergency room visits, calls to the physician and OTC drug use.
Conclusions: Insomnia is significantly associated with reduced HR-QOL and increased healthcare resource use in enrollees of managed-care organisations.
Similar articles
-
Prevalence of insomnia: a survey of the enrollees at five managed care organizations.Am J Manag Care. 1998 Jan;4(1):79-86. Am J Manag Care. 1998. PMID: 10179908
-
The economic impact of insomnia in managed care: a clearer picture emerges.Am J Manag Care. 2006 May;12(8 Suppl):S246-52. Am J Manag Care. 2006. PMID: 16686594
-
The burden of insomnia on individual function and healthcare consumption in Australia.Aust N Z J Public Health. 2012 Oct;36(5):462-8. doi: 10.1111/j.1753-6405.2012.00845.x. Epub 2012 Feb 23. Aust N Z J Public Health. 2012. PMID: 23025369
-
Treating the health, quality of life, and functional impairments in insomnia.J Clin Sleep Med. 2007 Feb 15;3(1):63-72. J Clin Sleep Med. 2007. PMID: 17557457 Review.
-
The state of insomnia and emerging trends.Am J Manag Care. 2007 Nov;13(5 Suppl):S117-20. Am J Manag Care. 2007. PMID: 18041871 Review.
Cited by
-
Insomnia and health services utilization in middle-aged and older adults: results from the Health and Retirement Study.J Gerontol A Biol Sci Med Sci. 2013 Dec;68(12):1512-7. doi: 10.1093/gerona/glt050. Epub 2013 May 9. J Gerontol A Biol Sci Med Sci. 2013. PMID: 23666943 Free PMC article.
-
Quality of sleep: associations with antiretroviral nonadherence.AIDS Patient Care STDS. 2011 Sep;25(9):517-24. doi: 10.1089/apc.2010.0375. Epub 2011 Jul 19. AIDS Patient Care STDS. 2011. PMID: 21770763 Free PMC article.
-
The prevalence of fatigue among Chinese nursing students in post-COVID-19 era.PeerJ. 2021 Apr 13;9:e11154. doi: 10.7717/peerj.11154. eCollection 2021. PeerJ. 2021. PMID: 33954035 Free PMC article.
-
Refractory insomnia and sleep-disordered breathing: a pilot study.Sleep Breath. 2004 Mar;8(1):15-29. doi: 10.1007/s11325-004-0015-5. Sleep Breath. 2004. PMID: 15026935
-
New drugs for insomnia: comparative tolerability of zopiclone, zolpidem and zaleplon.Drug Saf. 2003;26(4):261-82. doi: 10.2165/00002018-200326040-00004. Drug Saf. 2003. PMID: 12608888 Review.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical